Dermsquared

09/02/2026

A medieval castle replete with border guards, intelligence officers, and an invading army at the gates...

That’s where dermatologists Harrison Nguyen, MD, and Diego Ruiz Dasilva, MD, began their conversation about Type 2 inflammation and the immune system—something Dr DaSilva aptly called “humbling” in its complexity.

From barrier defense and innate immunity to adaptive responses, cytokines, and the heterogeneity that makes these diseases anything but simple, the discussion moved from immunology to your questions about what it all means in practice.

Don’t miss the full conversation and access our full PANP360 hub: your one-stop shop for dermatology education, practical tools, and more clinical insights. Visit our link in bio to level up now!

09/02/2026

Why has sunscreen innovation moved so slowly in the United States, and what does that mean for the products patients use today?​

In a new episode of Derms and Conditions, James Q. Del Rosso, DO, welcomes Darrell Rigel, MD, MS, to discuss the science, regulation, and everyday realities of photoprotection.​

They cover:​
☀️ The regulatory history behind US sunscreen filters​
☀️ Bemotrizinol and what a new UV filter could mean for sunscreen formulations​
☀️ How to address sunscreen misinformation with patients​
☀️ Photoprotection considerations across skin tones​

Tune in for a closer look at the history and science behind modern sunscreens and how dermatologists can navigate common questions about sun protection with their patients.​

​

Listen Now: https://bit.ly/3SCFIRD

​

08/29/2026

What might you miss if you stop at the most obvious explanation?​

In this “Spilling the Tea” episode of Derms and Conditions, James Q. Del Rosso, DO, shares clinical observations that highlight the value of looking more closely at findings, labeling, and the full patient picture.​

​
Topics include:​
-Scalp and nailfold findings that may offer clues to dermatomyositis​
-What “not recommended” in prescribing information does, and does not, mean​
-Why a thorough examination matters when assessing active vs fibrotic or scarred disease in HS​

A case of rhabdomyolysis in a patient receiving JAK inhibitor therapy that illustrates why an unexpected finding may have more than one potential explanation​

Tune in for observations that challenge clinicians to look beyond the initial impression and consider what else may be contributing.​

Listen here: https://dermsquared.com/podcasts/derms-and-conditions/season-6-episode-154​

​

08/27/2026

How well can you spot cutaneous lupus in different skin tones?

In this on-demand activity, Lauren Graham, MD, PhD, and Saakshi Khattri, MD, explore the diagnostic features that separate cutaneous lupus erythematosus (CLE) subtypes, review diagnostic considerations across skin colors, and identify where newer targeted options fit based on subtype, disease activity, and prior treatment.

Earn up to 0.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™.

Start the activity, ‘Seeing CLE Clearly: Optimizing Recognition and Enhancing Management of Cutaneous Lupus Erythematosus,’ at https://bit.ly/3SyM5W4

This activity is supported by an educational grant from Biogen.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared®. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

08/21/2026

How early can you recognize scarring alopecia?​

Early diagnosis can make a meaningful difference, yet some cicatricial alopecias can initially resemble nonscarring conditions, making them easy to overlook.​

In this episode of Derms and Conditions, James Q. Del Rosso, DO, and Andrea Murina, MD, discuss the clinical clues, diagnostic tools, and treatment considerations that can help clinicians intervene before permanent hair loss occurs:​

-Clinical clues that help distinguish scarring from nonscarring alopecias ​
-How trichoscopy can support diagnosis and guide biopsy selection ​
-Approaches to managing CCCA, lichen planopilaris, and discoid lupus erythematosus​

Listen to the full episode to hear how Drs Del Rosso and Murina approach early recognition, diagnosis, and management of scarring alopecias.​

Listen here: https://bit.ly/4c0GdLO

​

James Q. Del Rosso, DO, welcomes Andrea Murina, MD, to discuss the early recognition and management of scarring alopecias.

08/19/2026

What's driving the next wave of hidradenitis suppurativa (HS) therapies?

Harrison Nguyen, MD, MPH, MBA, and Andrea T Murina, MD walk through the mechanisms and trial data behind emerging HS treatments in 'Under the Skin: Targeting the Mechanisms Underlying Hidradenitis Suppurativa,' a new on-demand CME activity.

In this activity, you'll distinguish emerging HS therapies by mechanism of action and review the latest clinical evidence for new and emerging HS treatments.

Earn up to 0.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™.

Start the activity at https://bit.ly/4aLi5Mv

This activity is supported by an educational grant from Incyte.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared®. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

08/17/2026

The clinicians shaping dermatology have already booked their seats.

Join the field's leading faculty for four days of first-look clinical data and the sessions that set the year's agenda in derm.

Earn up to 24.5 CME credits, October 8 to 11 at the Wynn Las Vegas.

It sells out every year for a reason. Learn more at: https://utm.rocks/urQ4f



This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared®. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Nevada, Reno School of Medicine designates this live activity for a maximum of 24.5 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

08/13/2026

Alopecia areata severity can’t be captured by a SALT score alone.​

In this episode of The Spot Check, Jamie Restivo, PA-C, and Matthew Brunner, PA-C, walk through the patient journey from initial assessment and treatment selection to baseline testing, follow-up, and long-term management with deuruxolitinib.​

Brunner also gets into the practical details of initiating and monitoring treatment, including required CYP2C9 genotype testing, lab screening, vaccination and pregnancy considerations, photography, adherence, and the subtle early signs that may indicate response.​

The larger message is one NP/PAs know well: alopecia areata is not cosmetic, counseling cannot be rushed, and meaningful regrowth takes time.​

“This is a marathon, it’s not a sprint.”​

Listen to the full episode here: https://dermsquared.com/podcasts/the-spot-check-podcast/Season-2-episode-20​

​

08/12/2026

Five tips. Five minutes. One sharper approach to IL-13 inhibition for atopic dermatitis (AD).

Benjamin Ehst, MD, PhD, and Matthew Zirwas, MD, get straight to it in ‘Five in Five’ Tips to Targeting IL-13 in Atopic Dermatitis. They use the latest clinical data to differentiate the available IL-13-targeted biologics and share practical, evidence-based ways to personalize treatment plans for moderate-to-severe AD.

Earn up to 0.25 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™.

Start the activity at https://bit.ly/4fmMqne.

This activity is supported by an educational grant from Lilly.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared®. The Institute is accredited by the ACCME to provide continuing medical education for physicians.

The Institute for Continuing Healthcare Education designates this enduring activity for a maximum of 0.25 𝘈𝘔𝘈 𝘗𝘙𝘈 𝘊𝘢𝘵𝘦𝘨𝘰𝘳𝘺 1 𝘊𝘳𝘦𝘥𝘪𝘵(𝘴)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

08/12/2026

What questions does a new expert position paper raise about psoriasis treatment guidelines?​

In this episode of Derms and Conditions, James Q. Del Rosso, DO, and Joshua Burshtein, MD, discuss their recent JCAD expert position paper examining the intent and limitations of published psoriasis treatment guidelines and how they can better support individualized treatment decisions.​

Their conversation explores the intended role of treatment guidelines, the reality that published recommendations do not always keep pace with available therapies, how guidelines can affect treatment access when applied by third-party payers, and how clinicians balance published recommendations with the realities of individual patient care.​

Listen to the full episode: https://dermsquared.com/podcasts/derms-and-conditions/season-6-episode-152​

​